NSC185

Title: NSC185;
.beta.-[2-(3, 5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]glutarimide;
Acti-dione BR;
Acti-Aid;
Actidion;
Actidione;
Actidione PM;
Actidone;
Actispray;
ACTIDIONE;
Cicloheximide;
Cyclohemimide;
Cyclohexamide;
Cycloheximide;
CBC 500046;
CX;
CYCLOHEXIMIDE;
Glutarimide, 3-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]- (VAN 8CI);
Glutarimide, 3-[2-(3, 5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]- (VAN8CI);
Hizarocin;
Kaken;
Naramycin;
Naramycin A;
Neocycloheximide;
NARAMYCIN A;
NSC-185;
TZA;
U 4527;
WLN: T6VMVTJ E1YQ- BL6VTJ D1 F1;
2, 6-Piperidinedione, 4-[2-(3, 5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]-, [1S-[1.alpha.(S*), 3.alpha.,5.beta.]]- (9CI);
3-[2-(3, 5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]glutarimide;
4-[2-(3, 5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]-2,6-piperidinedione
US National Cancer Institute
URI: http://localhost:8080/xmlui/handle/CUHPOERS/119412

Show full item record

Files in this item

Files Size Format View
nsc000185_original.cml 7.894Kb chemical/x-cml View/Open
nsc000185_post-mopac.cml 7.209Kb chemical/x-cml View/Open

This item appears in the following Collection(s)

Search DSpace


Advanced Search

Browse